Position in OGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,283,741
+$303,512 QoQ
Shares Held
390,232
-53.1% QoQ
Ownership
0.149%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#80
of 625 holders
Holding Since
Jun 2021
19 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Derivatives in OGN
reported options exposure · as of Mar 31, 2026CallValue
$523,526
CallShares
87,400
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Squarepoint Ops LLC holds $1,171,914,058 across 14 Drug Manufacturers - General names. OGN ranks #9 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,247,079 | $316,720,653 | |
| 2 | LLY |
ELI LILLY & Co
|
245,569 | $294,542,850 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
1,823,224 | $230,346,120 | |
| 4 | MRK |
Merck & Co., Inc.
|
909,676 | $116,893,366 | |
| 5 | PFE |
Pfizer Inc
|
3,310,002 | $79,704,848 | |
| 6 | AMGN |
Amgen Inc
|
208,010 | $75,324,581 | |
| 7 | ABBV |
AbbVie Inc.
|
91,950 | $23,138,298 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
324,626 | $18,704,950 |
All Filings in OGN
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,283,741 | 390,232 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $523,526 | 87,400 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $4,980,229 | 831,424 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,587,882 | 360,932 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,944,219 | 275,676 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,127,739 | 116,502 | Shares | Defined | 2025-08-27 | |
| 2024-12-31 | $2,019,153 | 135,332 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $5,051,582 | 264,066 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $670,845 | 32,408 | Shares | Defined | 2024-08-14 | |
| 2023-12-31 | $20,827,065 | 1,444,318 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $448,825 | 25,854 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $10,170,762 | 488,744 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,005,127 | 42,735 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $9,172,882 | 328,424 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $10,960,583 | 468,401 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,951,226 | 146,703 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $690,042 | 19,755 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,984,039 | 97,998 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,207,652 | 67,327 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $615,367 | 20,336 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||